Jiali Wang
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exploring the Mechanism of Shenqi Fuzheng Injection on Alleviating EGFR-TKIs Resistance in Non-small Cell Lung Cancer: Integration of Clinical Observation, Network Pharmacology, and Experimental Validation.
Journal: Current pharmaceutical design
Published: January 13, 2026
VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 23, 2025
A Mendelian randomization study on the causal association of circulating cytokines with diabetic nephropathy.
Journal: Journal of diabetes investigation
Published: January 17, 2025
Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.
Journal: Pharmaceutical biology
Published: December 15, 2023
Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.
Journal: Journal of pharmacological sciences
Published: August 10, 2023
Is the Fixed Periodic Treatment Effective for the Tumor System without Complete Information?
Journal: Cancer management and research
Published: September 22, 2021
Optimizing Adaptive Therapy Based on the Reachability to Tumor Resistant Subpopulation.
Journal: Cancers
Published: August 26, 2021
Exploring the role of RALYL in Alzheimer's disease reserve by network-based approaches.
Journal: Alzheimer's research & therapy
Published: July 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026